Karas Eric
SEC insider (Form 3/4/5 filer). CIK 0001951287. Chief Commercial Officer at ARS Pharmaceuticals, Inc. (SPRY). 16 reported Form 4/5 transactions since Sep 2024; latest on Jun 12, 2026. Located in SAN DIEGO, CA.
Companies Karas Eric has filed insider reports for
- ARS Pharmaceuticals, Inc. (SPRY): Officer, Chief Commercial Officer
Karas Eric
CIK: 0001951287
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ARS Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Jun 12, 2026SPRY
ARS Pharmaceuticals, Inc.
ExerciseDirect25K shares at avg. $1.50$38K - Jun 12, 2026SPRY
ARS Pharmaceuticals, Inc.
SaleDirect25K shares at avg. $10.00$250K - Jan 2, 2026SPRY
ARS Pharmaceuticals, Inc.
AwardDirectStock option (right to buy)
240K shares- - Jul 1, 2025SPRY
ARS Pharmaceuticals, Inc.
SaleDirect15K shares at avg. $16.99$255K - Jul 1, 2025SPRY
ARS Pharmaceuticals, Inc.
ExerciseDirect15K shares at avg. $1.50$23K - Jun 18, 2025SPRY
ARS Pharmaceuticals, Inc.
ExerciseDirect15K shares at avg. $1.50$23K - Jun 18, 2025SPRY
ARS Pharmaceuticals, Inc.
SaleDirect15K shares at avg. $16.00$240K - Mar 20, 2025SPRY
ARS Pharmaceuticals, Inc.
SaleDirect10K shares at avg. $14.00$140K - Mar 20, 2025SPRY
ARS Pharmaceuticals, Inc.
ExerciseDirect10K shares at avg. $1.50$15K - Jan 2, 2025SPRY
ARS Pharmaceuticals, Inc.
AwardDirectStock option (right to buy)
152.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2026 | SPRY ARS Pharmaceuticals, Inc. | Exercise | 25,000 | $1.50 | $37,500 | Direct |
| Jun 12, 2026 | SPRY ARS Pharmaceuticals, Inc. | Sale | 25,000 | $10.00 | $250,000 | Direct |
| Jan 2, 2026 | SPRY ARS Pharmaceuticals, Inc. | Award Stock option (right to buy) | 240,000 | - | - | Direct |
| Jul 1, 2025 | SPRY ARS Pharmaceuticals, Inc. | Sale | 15,000 | $16.99 | $254,861 | Direct |
| Jul 1, 2025 | SPRY ARS Pharmaceuticals, Inc. | Exercise | 15,000 | $1.50 | $22,500 | Direct |
| Jun 18, 2025 | SPRY ARS Pharmaceuticals, Inc. | Exercise | 15,000 | $1.50 | $22,500 | Direct |
| Jun 18, 2025 | SPRY ARS Pharmaceuticals, Inc. | Sale | 15,000 | $16.00 | $240,000 | Direct |
| Mar 20, 2025 | SPRY ARS Pharmaceuticals, Inc. | Sale | 10,000 | $14.00 | $140,000 | Direct |
| Mar 20, 2025 | SPRY ARS Pharmaceuticals, Inc. | Exercise | 10,000 | $1.50 | $15,000 | Direct |
| Jan 2, 2025 | SPRY ARS Pharmaceuticals, Inc. | Award Stock option (right to buy) | 152,300 | - | - | Direct |
1-10 of 16 transactions